- Report
- February 2023
- 205 Pages
North America
From €3050EUR$3,450USD£2,655GBP
- Report
- February 2023
- 192 Pages
Asia Pacific
From €3050EUR$3,450USD£2,655GBP
- Report
- February 2023
- 205 Pages
Africa, Middle East
From €3050EUR$3,450USD£2,655GBP
- Report
- December 2022
- 267 Pages
Global
From €3934EUR$4,450USD£3,425GBP
- Report
- August 2023
- 150 Pages
Global
From €3403EUR$3,850USD£2,963GBP
€4287EUR$4,850USD£3,733GBP
- Report
- August 2024
- 142 Pages
Global
From €3978EUR$4,500USD£3,463GBP
- Report
- December 2024
- 150 Pages
Global
From €2968EUR$3,358USD£2,584GBP
€3492EUR$3,950USD£3,040GBP
- Report
- October 2024
- 99 Pages
Global
From €3500EUR$4,241USD£3,154GBP
- Report
- July 2024
- 132 Pages
Global
From €840EUR$950USD£731GBP
The Sepsis Test market is a subset of the Diagnostics industry, focused on the detection and diagnosis of sepsis. Sepsis is a life-threatening condition caused by the body's response to an infection, and early diagnosis is critical for successful treatment. Sepsis tests are used to detect the presence of sepsis-causing bacteria in the blood, and to identify the type of bacteria present. Tests may also be used to monitor the progress of treatment.
Sepsis tests are typically performed in a laboratory setting, and may include blood cultures, urine cultures, and other tests. Tests may also be performed using point-of-care devices, which allow for rapid diagnosis in the clinical setting.
Companies in the Sepsis Test market include Abbott, Becton Dickinson, bioMérieux, Cepheid, DiaSorin, and Roche. Show Less Read more